Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02825836
Brief Title: Phase I/II, First in Human, Dose Escalation Trial of TL 895 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Relapsed/Refractory Small Lymphocytic Lymphoma

First Submitted : June 1, 2016
First Submitted that Met QC Criteria : July 1, 2016
First Posted : July 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : September 14, 2021
Last Update Posted : September 16, 2021